Target intelligence / Profile preview

GJD2 divergent transcript (GJD2-DT)

Target
GJD2-DT
Molecular classification
Other (lncRNA, non-coding RNA)
01

Overview

GJD2 divergent transcript (GJD2-DT) is a non-coding RNA gene located on chromosome 15q14, classified as a long non-coding RNA (lncRNA). It is predicted bioinformatically to be involved in functions related to protein targeting to the membrane via the signal recognition particle pathway and signal sequence recognition, perhaps as part of the endoplasmic reticulum targeting machinery. There is currently no established protein product, and the biological relevance is predicted, not experimentally validated. Genomic studies have linked GJD2-DT to loci associated with prostate cancer risk, dilated cardiomyopathy, and hypertrophic cardiomyopathy, but there is no evidence it is a therapeutic target, nor are there known drugs that modulate its activity directly. No phenotypic biomarkers or safety concerns have been reported for GJD2-DT.

Other names
GJD2-DTGJD2 divergent transcript
02

Biological functions

SRP-dependent cotranslational protein targeting to membrane (predicted)Signal sequence recognition (predicted)Possible involvement in signal recognition particle, endoplasmic reticulum targeting (predicted)
03

Disease associations

Associated in genome-wide studies with risk loci for prostate cancer susceptibility (interaction with known risk-associated variants)Linked in variant studies with dilated cardiomyopathy and hypertrophic cardiomyopathy (as noted in variant-association databases, but not established as causal)

Beyond the preview

Go deeper on GJD2 divergent transcript (GJD2-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GJD2 divergent transcript (GJD2-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call